Brief: Shah Capital Recommends Immediate Formal Strategic Review For Sale Of Novavax
14/10/2025 11:00
Oct 14 (Reuters) - SHAH CAPITAL: SHAH CAPITAL: RECOMMENDS IMMEDIATE FORMAL STRATEGIC REVIEW FOR SALE OF NOVAVAX SHAH CAPITAL: CURRENTLY OWNS 7.2% OF NOVAVAX Further company coverage: NVAX.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Novavax
See all newsNovavax shareholder Shah Capital to step back from activist role
Brief: Mabion Signs Deal With Novavax Expanding Cooperation To Analytical Services For Early-Stage Pipeline Projects
Brief: Sanofi Spokesperson Says Nuvaxovid to Be Available Across U.S. for 2026-27 Respiratory Virus Season
US FDA approves updated COVID vaccines for 2026-27 season
US STOCKS-Wall St rises as yields ease, Moderna lifts healthcare stocks